Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity

NCT03083431 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

276

Enrollment

OTHER

Sponsor class

Conditions

Retinopathy of Prematurity

Interventions

DRUG: Propranolol
DRUG: Placebo

Sponsor

University of Zurich

Collaborators

[object Object]
[object Object]